NCT05714423 is a NA clinical trial of Mini-PCNL in Kidney Stone, sponsored by Services Hospital, Lahore.

Who is sponsoring NCT05714423?

NCT05714423 is sponsored by Services Hospital, Lahore.

What drugs are being tested in NCT05714423?

Interventions in NCT05714423: Mini-PCNL, RIRS.

What condition does NCT05714423 study?

NCT05714423 studies Kidney Stone.

Is NCT05714423 still recruiting?

NCT05714423 is currently completed. Last updated 6 February 2023.

Last reviewed 2023-02-06 · How we verify

NCT05714423

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery

Completed NA Last updated 6 February 2023

What this trial tests

NA trial testing Mini-PCNL in Kidney Stone in 150 participants. Completed in 31 December 2022.

Timeline

1 October 2020

Primary endpoint
30 November 2022

31 December 2022

Quick facts

Lead sponsor	Services Hospital, Lahore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	1 October 2020
Primary completion	30 November 2022
Estimated completion	31 December 2022
Sites	1 location across Pakistan

Drugs / interventions tested

Mini-PCNL
RIRS

Conditions studied

Kidney Stone — all drugs for Kidney Stone →

Sponsor

Services Hospital, Lahore

Who can join

Adults 18 to 80, any sex, with Kidney Stone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Due to the anatomic characteristics of the lower calyx, lower pole stones are difficult to be eliminated through the ureter, even if the stones had been fragmented. Retrograde intrarenal surgery (RIRS) can be used to deal with lower pole stones of 1.0-2.0 cm, while percutaneous nephrolithotripsy (PCNL) is mainly used to deal with lower pole stones with larger diameter or when RIRS failed to resolve the stone. This study was conducted to compare mini PCNL and retrograde intrarenal surgery (RIRS) for the management of lower pole kidney stones in terms of efficacy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mini-PCNL

Trials testing the same drug.

NCT03771365 — Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone · unknown

Other recruiting trials for Kidney Stone

Currently open trials in the same condition.

NCT06944223 — Oxalate and Citrate in Humans - Response to Citrate · NA · recruiting
NCT07071948 — A Single-Center Clinical Study on the Efficacy and Safety of VISOR · NA · recruiting
NCT06576661 — Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Be · NA · recruiting
NCT06210009 — Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease · NA · recruiting
NCT07238803 — Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. · NA · recruiting

Other Services Hospital, Lahore trials

Trials by the same sponsor.

NCT06239207 — Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia · Phase 2 · completed
NCT07395388 — Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy · NA · completed
NCT07473388 — Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel · NA · completed
NCT07493343 — EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers · NA · completed
NCT07496216 — Closed Versus Open Lateral Internal Sphincterotomy for Chronic Anal Fissure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05714423 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Services Hospital, Lahore
Last refreshed: 6 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing